Sort
15,842 grants matching “pancreatic cancer”
Basic Science Research in Digestive Diseases
$237,123Mark Donowitz · Johns Hopkins University · T32 · FY2015 · DK
Molecular Mechanisms for Growth Factor Action of Gastrin
$237,054University Of Michigan At Ann Arbor · R01 · FY2004 · DK
Molecular Mechanisms for Growth Factor Action of Gastrin
$237,054University Of Michigan At Ann Arbor · R01 · FY2002 · DK
Molecular Mechanisms for Growth Factor Action of Gastrin
$237,054University Of Michigan At Ann Arbor · R01 · FY2005 · DK
Molecular Mechanisms for Growth Factor Action of Gastrin
$237,054University Of Michigan At Ann Arbor · R01 · FY2003 · DK
Does Hyperglycemia Predict Pancreatic Cancer Diagnosis?
$237,021Suresh T. Chari · Mayo Clinic Rochester · R01 · FY2006 · CA
Supramolecular matrix materials for prostate cancer cell biology
$237,000Donald James Vander Griend · University Of Chicago · R21 · FY2016 · CA
Mechanism of SPARC peptide FSEC inhibition of angiogenesis in neuroblastoma
$237,000Susan L Cohn · University Of Chicago · R21 · FY2013 · NS
Molecular Mechanisms of p53 dependent longevity regulation
$236,946Johannes H Bauer · Southern Methodist University · R00 · FY2011 · AG
Regulation of mRNA Stability in Human Saliva
$236,938Viswanathan Palanisamy · Medical University Of South Carolina · R00 · FY2011 · DE
The Role of MicroRNAs in Cellular Quiescence
$236,772Hilary A Coller · University Of California Los Angeles · R01 · FY2012 · GM
Novel Hedgehog Receptors As Therapeutic Targets In Pancreatic Cancer
$236,749Benjamin Allen · University Of Michigan At Ann Arbor · R21 · FY2012 · CA
In Vivo Imaging, Dosimetry and Technology Transfer
$236,649Brian William Pogue · Massachusetts General Hospital · P01 · FY2011 · CA
Lentiviral engineered T cell immunotherapy in tumors overexpressing mesothelin
$236,588Boro Dropulic · Lentigen Corporation · R43 · FY2006 · CA
In Vivo Imaging, Dosimetry and Technology Transfer
$236,585Brian William Pogue · Massachusetts General Hospital · P01 · FY2012 · CA
Cancer Biology Training Program
$236,493Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2017 · CA
Repurposing Mycobacterium tuberculosis tRNase toxins for cancer chemotherapy
$236,333Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R21 · FY2022 · CA
Project 1: Combining PARP inhibition with radiation to sensitize HR proficient pancreatic cancers to immunotherapy
$236,326Meredith A Morgan · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology
$236,272Jonathan P Celli · University Of Massachusetts Boston · R00 · FY2014 · CA
Role of HSulf-1 Loss in Apoptosis and Drug Resistance
$236,215Viji Shridhar · Mayo Clinic Rochester · R01 · FY2006 · CA
Novel Approaches for Structural Determination of Cancer Stem Cell Glycans
$236,192Kristina Hakansson · University Of Michigan At Ann Arbor · R21 · FY2010 · CA
Oncogenic Synapses: cell-cell contacts enabling trogocytic-based metabolic interactions between pancreatic cancer and fibroblastic stromal cells
$236,146Igor Astsaturov · Research Inst Of Fox Chase Can Ctr · R21 · FY2019 · CA
Regulation of B1 Integrin Glycosylation by RAS
$236,089University Of Alabama At Birmingham · R01 · FY2002 · CA
P2 - Markers of Pancreatic Cancer Using a Glycoproteomic Approach
$236,084Mack T Ruffin · University Of Michigan At Ann Arbor · P50 · FY2013 · CA
Regulation of Ribosome Biogenesis During Stress
$236,000Shawn M Lyons · Boston University Medical Campus · R00 · FY2020 · GM